CEO says Novartis committed to long-term presence in Slovenia

Ljubljana, 5 July - As Swiss multinational Novartis is seeking to become a leading prescription drugs company, its CEO Vas Narasimhan says it will continue to look to expand its investments in Slovenia as it is committed to its long-term presence here.

Ljubljana Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters. Photo: Nebojša Tejić/STA

Ljubljana
Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters.
Photo: Nebojša Tejić/STA

Ljubljana Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters. Photo: Nebojša Tejić/STA

Ljubljana
Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters.
Photo: Nebojša Tejić/STA

Ljubljana Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters. Photo: Nebojša Tejić/STA

Ljubljana
Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters.
Photo: Nebojša Tejić/STA

Ljubljana Swiss multinational Novaris CEO Vas Narasimhan (left) giving an interview for the STA at pharmaceutical company Lek's headquarters. Photo: Nebojša Tejić/STA

Ljubljana
Swiss multinational Novaris CEO Vas Narasimhan (left) giving an interview for the STA at pharmaceutical company Lek's headquarters.
Photo: Nebojša Tejić/STA

The rest of this news item is available to subscribers.
The news item consists of 1.585 characters (without spaces) or 306 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

eho/uk/sm
© STA, 2018

The STA web pages use cookies to ensure proper functioning of all page features. By using our website, you agree to the use of cookies on all STA web pages.

I want to know more